Delivery Order SPE2DB20D1100-SPE2DB25FE1PD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg under a firm fixed-price contract valued at $20,551.98. The award, made on September 24, 2025, represents a non-competitive delivery order with an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,503.49 for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, firm fixed price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a typical transactional purchase under the company's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Celebrex 200 mg capsules (100-count units) with a ceiling value of $3,786.34. This competitive award employs firm fixed pricing under a delivery order contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a ceiling value of $3,349.86. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set to be completed by September 26, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Celebrex 200 mg capsules (100 count) with a contract value of $2,387.86. This firm fixed-price delivery order, which will be completed by August 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,597.37 firm fixed-price delivery order is for the supply of Celecoxib 200 mg capsules, a medication used to treat pain and inflammation. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp provides for the supply of Celebrex 200 mg capsules (100 count) with a ceiling value of $2,995.19 under a firm fixed price arrangement. The contract is not set aside and was competitively awarded by the Medical Supply Chain, a component of the Defense Logistics Agency. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for...
- On August 13, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,526.68 to AmerisourceBergen Drug Corp for 100 capsules of Celebrex 200 mg. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQEVU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,434.56 firm fixed-price delivery order is for the supply of 4568142809 Celecoxib 200 mg capsules, and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 Indefinite Delivery Contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1PDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) valued at $1,575.46. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support to military healthcare programs worldwide, enabling the company to supply a broad range of medications, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The delivery order fulfills immediate pharmaceutical needs for federal military and healthcare systems through this established contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/29/25 |